On Mar. 5, 2020, BioReference Laboratories, an OPKO Health company, announced it was offering a test for the novel coronavirus (2019-nCoV). With an extensive network of patient service centers and a national logistic network, BioReference provided expanded access to a COVID-19 testing across the U.S.